ATE33391T1 - Ionophor-polyether, deren verfahren zur herstellung und deren anwendung. - Google Patents

Ionophor-polyether, deren verfahren zur herstellung und deren anwendung.

Info

Publication number
ATE33391T1
ATE33391T1 AT85870125T AT85870125T ATE33391T1 AT E33391 T1 ATE33391 T1 AT E33391T1 AT 85870125 T AT85870125 T AT 85870125T AT 85870125 T AT85870125 T AT 85870125T AT E33391 T1 ATE33391 T1 AT E33391T1
Authority
AT
Austria
Prior art keywords
polyether
ionophor
application
production process
anhydrous
Prior art date
Application number
AT85870125T
Other languages
English (en)
Inventor
Lucien David
Ayala Humberto Leal
Marc Puygrenier
Original Assignee
Sanofi Sa
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Centre Nat Rech Scient filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE33391T1 publication Critical patent/ATE33391T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/47—Streptomyces albus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyethers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Fodder In General (AREA)
AT85870125T 1984-09-19 1985-09-17 Ionophor-polyether, deren verfahren zur herstellung und deren anwendung. ATE33391T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8414375A FR2570378B1 (fr) 1984-09-19 1984-09-19 Nouvel ionophore polyether, procede d'obtention et compositions veterinaires alimentaires ou therapeutiques le contenant
EP85870125A EP0179751B1 (de) 1984-09-19 1985-09-17 Ionophor-Polyether, deren Verfahren zur Herstellung und deren Anwendung

Publications (1)

Publication Number Publication Date
ATE33391T1 true ATE33391T1 (de) 1988-04-15

Family

ID=9307866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85870125T ATE33391T1 (de) 1984-09-19 1985-09-17 Ionophor-polyether, deren verfahren zur herstellung und deren anwendung.

Country Status (15)

Country Link
EP (1) EP0179751B1 (de)
JP (1) JPS61137888A (de)
KR (1) KR860002566A (de)
AT (1) ATE33391T1 (de)
AU (1) AU572691B2 (de)
CA (1) CA1308681C (de)
DE (1) DE3562092D1 (de)
DK (1) DK159321C (de)
ES (1) ES8607292A1 (de)
FR (1) FR2570378B1 (de)
GR (1) GR852259B (de)
IL (1) IL76458A0 (de)
NZ (1) NZ213521A (de)
PT (1) PT81134B (de)
ZA (1) ZA857050B (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2097053A2 (en) * 1970-07-30 1972-03-03 Agronomique Inst Nat Rech Grisorixin - insecticidal and acaricidal antibiotic
AU531276B2 (en) * 1978-11-29 1983-08-18 F. Hoffmann-La Roche & Co. Antibacterial urethane derivatives
BG32647A1 (en) * 1981-03-11 1982-09-15 Zakharieva Polyether antibiotic complex and method for its obtaining
BG32648A1 (en) * 1981-03-11 1982-09-15 Gesheva Polyether antibiotic complex and method for its obtaining
US4361649A (en) * 1981-07-20 1982-11-30 Pfizer Inc. Polycyclic ether antibiotic
US4542027A (en) * 1984-02-23 1985-09-17 Syntex (U.S.A.) Inc. Laidlomycin phenylcarbamate

Also Published As

Publication number Publication date
DK159321C (da) 1991-03-11
FR2570378B1 (fr) 1987-05-22
DK421385A (da) 1986-03-20
GR852259B (de) 1986-01-17
PT81134B (pt) 1988-01-22
ES8607292A1 (es) 1986-05-16
DK421385D0 (da) 1985-09-17
EP0179751A1 (de) 1986-04-30
AU4744385A (en) 1986-03-27
PT81134A (en) 1985-10-01
FR2570378A1 (fr) 1986-03-21
AU572691B2 (en) 1988-05-12
CA1308681C (en) 1992-10-13
EP0179751B1 (de) 1988-04-06
DK159321B (da) 1990-10-01
ES547079A0 (es) 1986-05-16
IL76458A0 (en) 1986-01-31
DE3562092D1 (en) 1988-05-11
JPS61137888A (ja) 1986-06-25
KR860002566A (ko) 1986-04-26
NZ213521A (en) 1988-06-30
ZA857050B (en) 1987-05-27

Similar Documents

Publication Publication Date Title
ATA122485A (de) Verfahren zur herstellung von neuen 1,4-dihydro-4-oxonaphthyridin-derivaten und deren salzen
AT363491B (de) Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen
AT357553B (de) Verfahren zur herstellung von neuen 2-(2,2- diarylalkyl)-1-azabicyclo(2.2.2)octanen und von deren salzen
DE3778682D1 (de) Verfahren zur herstellung nasaler loesungen enthaltend synthetisches human calcitonin.
AT357558B (de) Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkyl-benzol- sulfonylharnstoffen und von deren salzen
AT375369B (de) Verfahren zur herstellung neuer 1,2,4-oxadiazolin-5-on-derivate sowie von deren salzen
ATA112277A (de) Verfahren zur herstellung von neuen 2,9-dioxa- tricyclo (4,3,1,03,7) decanen und deren salzen
AT384806B (de) Verfahren zur herstellung von neuen 4-aryl-2-methyl-1,2,3,4-tetrahydro-isochinolinderivaten und deren salzen
AU572691B2 (en) Polyether ionophores
AT352139B (de) Verfahren zur herstellung von neuen 2,9- dioxatricyclo-(4,3,1,03,7)decanen und deren salzen
AT359070B (de) Verfahren zur herstellung von neuen 2,4-diamino -5-benzylpyrimidinen und deren salzen
AT364841B (de) Verfahren zur herstellung von neuen 1,2-benzisothiazolen und deren saeureadditionssalzen
AT373247B (de) Verfahren zur herstellung neuer 1,2,4-oxadiazin -derivate sowie von deren salzen
AT361002B (de) Verfahren zur herstellung von neuen 2,9- dioxatricyclo(4,3,1,03,7)decanen und deren salzen
AT350520B (de) Verfahren zur herstellung von neuen 7-amino- methyl-5,6,7-trihydro-2-substituierten-benzo- cyclohept-8-enen sowie deren saeureadditions- salzen
ATA328383A (de) Verfahren zur herstellung neuer 1,2,4-qxadiazolin -5-on-derivaten sowie von deren salzen
ATE56974T1 (de) Carbapenemverbindungen und deren herstellung.
AT375658B (de) Verfahren zur herstellung neuer 1,2,4-oxadiazin- derivate sowie von deren salzen
ATA27481A (de) Verfahren zur herstellung von substituierten allylaminen sowie von deren stereoisomeren, hydraten und pharmazeutisch akzeptablen salzen
ATA313783A (de) Verfahren zur herstellung von neuen 4,5,6,7tetrahydroisoindolderivaten und von deren salzen
ATA296279A (de) Verfahren zur herstellung von neuen (1,2- -dihydro-2-oxo-nicotinamido)-alkylbenzosulfo- nylharnstoffen und von deren salzen
AT363456B (de) Verfahren zur herstellung von neuen 1,1-diaryl-3-aminoalkanen, deren stereoisomeren und deren saeureadditionssalzen
ATA493380A (de) Verfahren zur herstellung von neuen 1,1-diaryl-3- aminoalkenen, deren stereoisomeren und deren saeureadditionssalzen
ATA73980A (de) Verfahren zur herstellung von neuen 2,9- -dioxatricyclo(4,3,1,03,7)decanen und deren salzen
ATA73880A (de) Verfahren zur herstellung von neuen 2,9- -dioxatricyclo(4,3,1,03,7)decanen und deren salzen